Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients
Status:
Unknown status
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
Research design: randomized, double-blind, placebo-controlled crossover study to evaluate the
putative interference of low-dose aspirin (for 8 weeks) on enalapril antiproteinuric
properties in microalbuminuric type 2 diabetes mellitus patients